"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country
The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 heal...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 55; no. 2; pp. 584 - 593 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.02.2012
Wiley Wolters Kluwer Health, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free‐living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m2) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012) |
---|---|
AbstractList | The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m2) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012) The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in ), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m super(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 plus or minus 1.78 versus 5.51 plus or minus 1.59 and 6.60 plus or minus 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 plus or minus 5.49 versus 5.63 plus or minus 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. Conclusion: LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. (Hepatology 2012) The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups. LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups.UNLABELLEDThe liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and also in patients with liver disease. In view of this objective, LSM was performed by transient elastography (TE) using FibroScan in 437 healthy subjects with normal alanine aminotransferase (ALT) levels, recruited from a free-living population of the Birbhum Population Project (BIRPOP; www.shds.in), a Health and Demographic Surveillance System (HDSS), and from 274 patients with liver disease attending the Hepatology Clinic of the School of Digestive and Liver Diseases (SDLD; Institute of Post Graduate Medical Education & Research [IPGME&R], Kolkata, India) including 188 with nonalcoholic fatty liver disease (NAFLD) and 86 with chronic hepatitis of viral and other etiologies. Liver biopsy was performed in 125 patients. The range of normal values for LSM, defined by 5th and 95th percentile values in healthy subjects, was 3.2 and 8.5 kPa, respectively. Healthy subjects with a lower body mass index (BMI; < <18.5 kg/m(2)) had a higher LSM compared with subjects who had a normal BMI; this LSM value was comparable to that of obese subjects (6.05 ± 1.78 versus 5.51 ± 1.59 and 6.60 ± 1.21, P = 0.016 and 0.349, respectively). Liver disease patients without histologic fibrosis had significantly higher LSM values compared with healthy subjects (7.52 ± 5.49 versus 5.63 ± 1.64, P < 0.001). Among the histologic variables, stage of fibrosis was the only predictor for LSM. LSM did not correlate with inflammatory activity and ALT in both NAFLD and chronic hepatitis groups.LSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease.CONCLUSIONLSM varies between 3.2 and 8.5 kPa in healthy subjects of South Asian origin. Both lean and obese healthy subjects have higher LSM values compared with subjects with normal BMI. Liver stiffness begins to increase even before fibrosis appears in patients with liver disease. |
Author | Mukherjee, Partha S. Das, Kausik Das, Kshaunish Santra, Amal Chowdhury, Abhijit Ahmed, Sk. Mahiuddin Mridha, Asit R. Dhali, Gopal K. Sarkar, Rajib |
Author_xml | – sequence: 1 givenname: Kausik surname: Das fullname: Das, Kausik organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 2 givenname: Rajib surname: Sarkar fullname: Sarkar, Rajib organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 3 givenname: Sk. Mahiuddin surname: Ahmed fullname: Ahmed, Sk. Mahiuddin organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 4 givenname: Asit R. surname: Mridha fullname: Mridha, Asit R. organization: Department of Pathology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 5 givenname: Partha S. surname: Mukherjee fullname: Mukherjee, Partha S. organization: Liver Foundation, West Bengal, India – sequence: 6 givenname: Kshaunish surname: Das fullname: Das, Kshaunish organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 7 givenname: Gopal K. surname: Dhali fullname: Dhali, Gopal K. organization: Department of Gastroenterology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 8 givenname: Amal surname: Santra fullname: Santra, Amal organization: Department of the Center for Liver Research, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India – sequence: 9 givenname: Abhijit surname: Chowdhury fullname: Chowdhury, Abhijit email: achowdhury2002@yahoo.co.in organization: Department of Department of Hepatology, School of Digestive and Liver Diseases (SDLD), Institute of Post Graduate Medical Education & Research (IPGME&R), Kolkata, India |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25589053$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21952989$$D View this record in MEDLINE/PubMed |
BookMark | eNp90s1u1DAQB_AIFdEPOPACyCpCtIe0jmM7MbeqKlukpRQB4mg5zqTr4tjBThb2KXhlTHcXpAo4WRr9_mONPfvZjvMOsuxpgU8KjMnpAoYTQrmgD7K9gpEqL0uGd7I9TCqci6IUu9l-jLcYY0FJ_SjbJYVgRNRiL_txeOVDr-whsmYJAcXRdJ2DGFEPKk4B0NH8w9tjtFR2gohUKizMzSJJ41DjxwWyoBxSrkW-gQip3JqlaSdl4yt0hgY_TFaNxru8URHadMHUrlAXfI8UamEJ1g_G3SDtJzeG1ePsYZei8GRzHmSfXl98PL_M5-9mb87P5rlmhaA5rTmpQdEaSNtwAMqw0AwEb7HmNdWspR0QSklDKCGa4KZkFS8qzHUKcVUeZC_XfYfgv6bJRtmbqMFa5cBPUYqiFmVJBUny6L-yqCrOec0YS_T5PXrrp-DSHEklQxISST3bqKnpoZVDML0KK7n9lARebICKWtkuKKdN_OMYqwVmZXKna6eDjzFAJ7UZ7956DMpYWWD5az1kWg95tx4pcXwvsW36N7vp_s1YWP0bysuL620iXydMHOH774QKXySvyorJz1czWc_I_Lou3st5-RMK1ta- |
CODEN | HPTLD9 |
CitedBy_id | crossref_primary_10_14309_ajg_0000000000000357 crossref_primary_10_1016_j_jaim_2020_12_015 crossref_primary_10_1111_tri_12073 crossref_primary_10_1093_ofid_ofw121 crossref_primary_10_3748_wjg_v28_i18_2021 crossref_primary_10_1371_journal_pone_0085067 crossref_primary_10_1016_j_jhep_2021_04_044 crossref_primary_10_1097_MEG_0000000000001092 crossref_primary_10_5005_jp_journals_10013_1121 crossref_primary_10_2478_rjim_2018_0034 crossref_primary_10_1093_carcin_bgx145 crossref_primary_10_1002_jmri_24084 crossref_primary_10_1007_s10620_014_3293_1 crossref_primary_10_1016_j_ultrasmedbio_2015_03_007 crossref_primary_10_22141_2308_2097_56_4_2022_519 crossref_primary_10_1007_s00330_012_2748_z crossref_primary_10_1016_j_dld_2016_07_020 crossref_primary_10_1080_15476286_2020_1768353 crossref_primary_10_1002_hep_27981 crossref_primary_10_1111_liv_12136 crossref_primary_10_4103_ijem_IJEM_31_18 crossref_primary_10_1007_s00261_020_02717_x crossref_primary_10_5005_jp_journals_10018_1067 crossref_primary_10_1371_journal_pone_0147879 crossref_primary_10_1186_s40001_023_01205_4 crossref_primary_10_5009_gnl16078 crossref_primary_10_1016_S1665_2681_19_31391_2 crossref_primary_10_1002_hep_25712 crossref_primary_10_1016_j_ultrasmedbio_2014_05_008 crossref_primary_10_1016_j_gene_2012_07_077 crossref_primary_10_1002_hep_25714 crossref_primary_10_1111_jgh_12318 crossref_primary_10_3389_fimmu_2022_975027 crossref_primary_10_1111_jgh_13762 crossref_primary_10_3390_nu14142808 crossref_primary_10_1111_liv_12623 crossref_primary_10_1007_s10620_021_07049_4 crossref_primary_10_1097_RUQ_0000000000000522 crossref_primary_10_1016_j_jceh_2022_10_008 crossref_primary_10_1002_hep_28843 crossref_primary_10_15406_ghoa_2016_05_00145 crossref_primary_10_1016_j_clinre_2019_06_007 crossref_primary_10_1016_j_jhep_2015_04_006 crossref_primary_10_1093_gastro_goae024 crossref_primary_10_1093_gastro_got007 crossref_primary_10_1186_s40001_023_01543_3 crossref_primary_10_1002_jgh3_12878 crossref_primary_10_1016_j_cgh_2022_01_015 crossref_primary_10_1002_jcu_23888 crossref_primary_10_1016_j_cgh_2018_08_069 crossref_primary_10_1016_j_jhepr_2020_100067 crossref_primary_10_1371_journal_pone_0203486 crossref_primary_10_1371_journal_pone_0110012 crossref_primary_10_1016_S1665_2681_19_31341_9 crossref_primary_10_1155_2015_624596 crossref_primary_10_4254_wjh_v5_i5_264 crossref_primary_10_1136_gutjnl_2018_317334 crossref_primary_10_1016_j_cgh_2012_09_025 crossref_primary_10_1055_s_0044_1782163 crossref_primary_10_1111_1751_2980_12868 crossref_primary_10_1016_j_ultrasmedbio_2012_11_015 crossref_primary_10_1016_S2468_1253_17_30034_1 crossref_primary_10_1371_journal_pone_0149843 crossref_primary_10_1093_ofid_ofw156 crossref_primary_10_1111_jgh_14311 crossref_primary_10_5582_ddt_2019_01009 crossref_primary_10_1002_ijc_33111 crossref_primary_10_1038_ajg_2012_331 crossref_primary_10_7863_ultra_14_10001 |
Cites_doi | 10.1111/j.1440-1746.2007.05002.x 10.1172/JCI116769 10.1093/ije/dyl244 10.1002/hep.22056 10.1152/ajpgi.00032.2007 10.1016/S0140-6736(08)60383-9 10.1210/jc.2008-1595 10.1136/gut.2010.221382 10.1016/S0016-5085(19)35563-5 10.1002/hep.21665 10.1016/j.jhep.2009.02.010 10.1002/hep.23425 10.1002/hep.22577 10.1016/j.jhep.2010.06.022 10.1002/hep.23567 10.1016/S0168-8278(99)80297-9 10.1053/gast.2002.36061 10.1053/j.gastro.2011.02.058 10.1002/hep.21306 10.1016/j.jhep.2009.11.018 10.1002/hep.22759 10.1002/hep.510240201 10.1186/1471-230X-10-40 10.1002/hep.21347 10.1016/j.jhep.2010.07.033 10.1016/j.jhep.2008.02.008 10.3851/IMP1570 10.1002/hep.20701 10.1007/BF00280883 10.1115/1.4002369 10.1016/j.cgh.2008.03.005 10.1053/j.gastro.2008.02.075 10.1136/gut.2007.126417 10.1053/jhep.2003.50157 10.1016/S0140-6736(05)67402-8 10.1177/016173461003200405 10.1371/journal.pone.0003857 10.1620/tjem.139.43 10.1111/j.1440-1746.2005.04070.x 10.1016/j.jhep.2007.11.020 |
ContentType | Journal Article |
Copyright | Copyright © 2011 American Association for the Study of Liver Diseases 2015 INIST-CNRS Copyright © 2011 American Association for the Study of Liver Diseases. |
Copyright_xml | – notice: Copyright © 2011 American Association for the Study of Liver Diseases – notice: 2015 INIST-CNRS – notice: Copyright © 2011 American Association for the Study of Liver Diseases. |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/hep.24694 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 593 |
ExternalDocumentID | 3958150871 21952989 25589053 10_1002_hep_24694 HEP24694 ark_67375_WNG_8G2LP81Q_L |
Genre | article Journal Article |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AANHP ABWVN ACLDA ACRPL ACYXJ ADNMO AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW ACIJW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
ID | FETCH-LOGICAL-c5194-48628ea48e2db6ee4509c5e96d0c684c5d4fe2442b2422c20b35761706ca486a3 |
IEDL.DBID | DR2 |
ISSN | 0270-9139 1527-3350 |
IngestDate | Fri Jul 11 10:28:22 EDT 2025 Fri Jul 11 16:14:57 EDT 2025 Fri Jul 25 09:50:45 EDT 2025 Thu Apr 03 07:02:01 EDT 2025 Mon Jul 21 09:12:48 EDT 2025 Thu Apr 24 22:55:47 EDT 2025 Tue Jul 01 03:33:29 EDT 2025 Wed Jan 22 17:01:43 EST 2025 Wed Oct 30 09:52:18 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Human Obesity Liver Nutrition disorder Gastroenterology Developing countries Nutritional status |
Language | English |
License | CC BY 4.0 Copyright © 2011 American Association for the Study of Liver Diseases. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5194-48628ea48e2db6ee4509c5e96d0c684c5d4fe2442b2422c20b35761706ca486a3 |
Notes | ArticleID:HEP24694 ark:/67375/WNG-8G2LP81Q-L Potential conflict of interest: Nothing to report. istex:4A158DB1B346C3467BB5E22289EE80F6A5C533B4 fax: +913322235435 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 21952989 |
PQID | 1766825559 |
PQPubID | 996352 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_918933492 proquest_miscellaneous_1776668555 proquest_journals_1766825559 pubmed_primary_21952989 pascalfrancis_primary_25589053 crossref_citationtrail_10_1002_hep_24694 crossref_primary_10_1002_hep_24694 wiley_primary_10_1002_hep_24694_HEP24694 istex_primary_ark_67375_WNG_8G2LP81Q_L |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2012 |
PublicationDateYYYYMMDD | 2012-02-01 |
PublicationDate_xml | – month: 02 year: 2012 text: February 2012 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2012 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley – name: Wolters Kluwer Health, Inc |
References | Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis by transient elastography. J Hepatol 2008; 48: 835-847. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993; 92: 1795-1804. Bedossa P, Poynard T; The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293. Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. HEPATOLOGY 2008; 48: 1718-1723. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. HEPATOLOGY 2003; 37: 802-809. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526. Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008; 6: 828-831. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613. Farrell GC, Chitturi S, Lau GKK, Sollano JD, for the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777. Roan E. The effect of Glisson's capsule on the superficial elasticity measurements of the liver. J Biomech Eng 2010; 132: 104-105. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50. Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 2010; 10: 40. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449-1457. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984. Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010; 15: 617-631. Orescanin M, Qayyum MA, Toohey KS, Insana MF. Dispersion and shear modulus measurements of porcine liver. Ultrason Imaging 2010; 32: 255-266. Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1331. Food and Agriculture Organization of the United Nations. The double burden of malnutrition: case studies from six developing countries. FAO Food Nutr Pap 2006; 84: 1-334. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595. Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659. Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis 2009; 18: 57-60. Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? HEPATOLOGY 2006; 44: 513-514. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. HEPATOLOGY 2010; 51: 828-835. Ghany MG, Strader DB, Thomas DL, Seef LB. AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374. Vergniol J, Foucher J, Terrebonne E, Bernard PH, Bail BL, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979. Kleiner DE, Brunt EM, Natta MV, Behling C, Contos MJ, Cummings OW, et al. for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. Quigley MA. Shifting burden of disease-epidemiological transition in India. Int J Epidemiol 2006; 35: 1530-1531. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974. Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3: e3857. Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-G1154. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958; 35: 190-199. Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard when everything else fails. J Hepatol 2009; 50: 1267-1268. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384. Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20: 1712-1720. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30. 1983; 139 2004; 363 1985; 28 2010; 32 2010; 10 2010; 15 2006; 35 2011; 60 1958; 35 2005; 41 2003; 37 2005; 20 2011; 54 2003; 38 2008; 6 2008; 3 2008; 93 2007; 56 2009; 49 2006; 84 2007; 293 2009; 50 2006; 44 2005; 366 1993; 92 2002; 123 2010; 132 2008; 47 2008; 48 1999; 31 1992; 24 2008; 134 2011; 140 1996; 24 2007; 22 2007; 45 2010; 52 2010; 51 2008; 371 2009; 18 Lok (R23-27-20241201) 2007; 45 Roulot (R10-27-20241201) 2008; 48 Castera (R7-27-20241201) 2010; 51 Rockey (R47-27-20241201) 1993; 92 Farrell (R21-27-20241201) 2007; 22 Vergniol (R2-27-20241201) 2011; 140 Kleiner (R26-27-20241201) 2005; 41 Millonig (R36-27-20241201) 2008; 48 Alvarez (R24-27-20241201) 1999; 31 Misra (R14-27-20241201) 2008; 93 Poynard (R8-27-20241201) 2008; 3 Bedossa (R4-27-20241201) 1996; 24 Roulot (R6-27-20241201) 2011; 60 Orescanin (R32-27-20241201) 2010; 32 (R30-27-20241201) 2006; 84 Schuppan (R20-27-20241201) 2008; 371 (R13-27-20241201) 2004; 363 Rockey (R46-27-20241201) 1992; 24 Sirli (R31-27-20241201) 2009; 18 Vizzutti (R34-27-20241201) 2007; 45 Chowdhury (R15-27-20241201) 2003; 37 Ghany (R22-27-20241201) 2009; 49 Millonig (R35-27-20241201) 2010; 52 Bedossa (R44-27-20241201) 2003; 38 Georges (R9-27-20241201) 2007; 293 Chowdhury (R16-27-20241201) 2005; 20 Das (R12-27-20241201) 2010; 51 Sagir (R37-27-20241201) 2008; 47 Corpechot (R11-27-20241201) 2006; 44 Williams (R28-27-20241201) 2006; 44 Quigley (R29-27-20241201) 2006; 35 Yoneda (R38-27-20241201) 2007; 56 Matthews (R19-27-20241201) 1985; 28 Gaia (R39-27-20241201) 2011; 54 FriedrichRust (R5-27-20241201) 2008; 134 Castera (R1-27-20241201) 2008; 48 Menghini (R25-27-20241201) 1958; 35 Poynard (R41-27-20241201) 2010; 10 Poynard (R42-27-20241201) 2010; 15 Roan (R33-27-20241201) 2010; 132 Kumar (R3-27-20241201) 2008; 134 Yajima (R17-27-20241201) 1983; 139 Jacqueminet (R40-27-20241201) 2008; 6 Tsochatzis (R43-27-20241201) 2011; 54 Alberti (R18-27-20241201) 2005; 366 Green (R27-27-20241201) 2002; 123 Poynard (R45-27-20241201) 2009; 50 22419516 - Hepatology. 2012 Sep;56(3):1183-4; author reply 1184-5 |
References_xml | – reference: Ghany MG, Strader DB, Thomas DL, Seef LB. AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374. – reference: Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938. – reference: Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. HEPATOLOGY 2003; 37: 802-809. – reference: Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? HEPATOLOGY 2006; 44: 513-514. – reference: Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384. – reference: Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. HEPATOLOGY 2008; 48: 1718-1723. – reference: Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613. – reference: Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062. – reference: Food and Agriculture Organization of the United Nations. The double burden of malnutrition: case studies from six developing countries. FAO Food Nutr Pap 2006; 84: 1-334. – reference: Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595. – reference: Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974. – reference: Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297. – reference: Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526. – reference: Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851. – reference: Bedossa P, Poynard T; The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293. – reference: Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard when everything else fails. J Hepatol 2009; 50: 1267-1268. – reference: Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659. – reference: Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3: e3857. – reference: Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958; 35: 190-199. – reference: WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163. – reference: Orescanin M, Qayyum MA, Toohey KS, Insana MF. Dispersion and shear modulus measurements of porcine liver. Ultrason Imaging 2010; 32: 255-266. – reference: Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539. – reference: Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71. – reference: Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984. – reference: Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602. – reference: Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993; 92: 1795-1804. – reference: Vergniol J, Foucher J, Terrebonne E, Bernard PH, Bail BL, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979. – reference: Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30. – reference: Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449-1457. – reference: Roan E. The effect of Glisson's capsule on the superficial elasticity measurements of the liver. J Biomech Eng 2010; 132: 104-105. – reference: Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1331. – reference: Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. HEPATOLOGY 2010; 51: 828-835. – reference: Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis by transient elastography. J Hepatol 2008; 48: 835-847. – reference: Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384. – reference: Quigley MA. Shifting burden of disease-epidemiological transition in India. Int J Epidemiol 2006; 35: 1530-1531. – reference: Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50. – reference: Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210. – reference: Farrell GC, Chitturi S, Lau GKK, Sollano JD, for the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777. – reference: Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203. – reference: Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010; 15: 617-631. – reference: Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-G1154. – reference: Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis 2009; 18: 57-60. – reference: Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. – reference: Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 2010; 10: 40. – reference: Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20: 1712-1720. – reference: Kleiner DE, Brunt EM, Natta MV, Behling C, Contos MJ, Cummings OW, et al. for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321. – reference: Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008; 6: 828-831. – volume: 366 start-page: 1059 year: 2005 end-page: 1062 article-title: The metabolic syndrome—a new worldwide definition publication-title: Lancet – volume: 44 start-page: 513 year: 2006 end-page: 514 article-title: Gender and liver: is the liver stiffness weaker in weaker sex? publication-title: HEPATOLOGY – volume: 49 start-page: 1335 year: 2009 end-page: 1374 article-title: AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update publication-title: Hepatology – volume: 45 start-page: 507 year: 2007 end-page: 539 article-title: Chronic hepatitis B publication-title: Hepatology – volume: 371 start-page: 838 year: 2008 end-page: 851 article-title: Liver cirrhosis publication-title: Lancet – volume: 51 start-page: 1593 year: 2010 end-page: 1602 article-title: Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease publication-title: HEPATOLOGY – volume: 123 start-page: 1367 year: 2002 end-page: 1384 article-title: AGA technical review on the evaluation of liver chemistry tests publication-title: Gastroenterology – volume: 44 start-page: 521 year: 2006 end-page: 526 article-title: Global challenges in liver disease publication-title: Hepatology – volume: 84 start-page: 1 year: 2006 end-page: 334 article-title: The double burden of malnutrition: case studies from six developing countries publication-title: FAO Food Nutr Pap – volume: 51 start-page: 828 year: 2010 end-page: 835 article-title: Pitfalls of liver stiffness measurement: a 5‐year prospective study of 13,369 examinations publication-title: HEPATOLOGY – volume: 93 start-page: S9 year: 2008 end-page: S30 article-title: Obesity and the metabolic syndrome in developing countries publication-title: J Clin Endocrinol Metab – volume: 24 start-page: 193 year: 1992 end-page: 203 article-title: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture publication-title: J Submicrosc Cytol Pathol – volume: 48 start-page: 835 year: 2008 end-page: 847 article-title: Non‐invasive evaluation of liver fibrosis by transient elastography publication-title: J Hepatol – volume: 35 start-page: 190 year: 1958 end-page: 199 article-title: One‐second needle biopsy of the liver publication-title: Gastroenterology – volume: 45 start-page: 1290 year: 2007 end-page: 1297 article-title: Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis publication-title: Hepatology – volume: 47 start-page: 592 year: 2008 end-page: 595 article-title: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage publication-title: Hepatology – volume: 54 start-page: 650 year: 2011 end-page: 659 article-title: Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta‐analysis of diagnostic accuracy publication-title: J Hepatol – volume: 41 start-page: 1313 year: 2005 end-page: 1321 article-title: for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: HEPATOLOGY – volume: 48 start-page: 1718 year: 2008 end-page: 1723 article-title: Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis publication-title: HEPATOLOGY – volume: 37 start-page: 802 year: 2003 end-page: 809 article-title: Hepatitis C virus infection in the general population: a community‐based study in West Bengal, India publication-title: HEPATOLOGY – volume: 28 start-page: 412 year: 1985 end-page: 419 article-title: Homeostasis model assessment: insulin resistance and B‐cell function from fasting glucose and insulin concentrations in man publication-title: Diabetologia – volume: 54 start-page: 64 year: 2011 end-page: 71 article-title: Reliability of transient elastography for the detection of fibrosis in non‐alcoholic fatty liver disease and chronic viral hepatitis publication-title: J Hepatol – volume: 38 start-page: 1449 year: 2003 end-page: 1457 article-title: Sampling variability of liver fibrosis in chronic hepatitis C publication-title: HEPATOLOGY – volume: 35 start-page: 1530 year: 2006 end-page: 1531 article-title: Shifting burden of disease—epidemiological transition in India publication-title: Int J Epidemiol – volume: 31 start-page: 929 year: 1999 end-page: 938 article-title: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis publication-title: J Hepatol – volume: 50 start-page: 1267 year: 2009 end-page: 1268 article-title: Liver biopsy: the best standard when everything else fails publication-title: J Hepatol – volume: 32 start-page: 255 year: 2010 end-page: 266 article-title: Dispersion and shear modulus measurements of porcine liver publication-title: Ultrason Imaging – volume: 139 start-page: 43 year: 1983 end-page: 50 article-title: Ultrasonographical diagnosis of fatty liver: significance of the liver‐kidney contrast publication-title: Tohoku J Exp Med – volume: 52 start-page: 206 year: 2010 end-page: 210 article-title: Liver stiffness is directly influenced by central venous pressure publication-title: J Hepatol – volume: 140 start-page: 1970 year: 2011 end-page: 1979 article-title: Noninvasive tests for fibrosis and liver stiffness predict 5‐year outcomes of patients with chronic hepatitis C publication-title: Gastroenterology – volume: 56 start-page: 1330 year: 2007 end-page: 1331 article-title: Transient elastography in patients with non‐alcoholic fatty liver disease (NAFLD) publication-title: Gut – volume: 6 start-page: 828 year: 2008 end-page: 831 article-title: Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes publication-title: Clin Gastroenterol Hepatol – volume: 132 start-page: 104 year: 2010 end-page: 105 article-title: The effect of Glisson's capsule on the superficial elasticity measurements of the liver publication-title: J Biomech Eng – volume: 60 start-page: 977 year: 2011 end-page: 984 article-title: Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community‐based population aged over 45 years publication-title: Gut – volume: 48 start-page: 606 year: 2008 end-page: 613 article-title: Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome publication-title: J Hepatol – volume: 22 start-page: 775 year: 2007 end-page: 777 article-title: Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia‐Pacific region: executive summary publication-title: J Gastroenterol Hepatol – volume: 15 start-page: 617 year: 2010 end-page: 631 article-title: Biomarkers of liver injury for hepatitis clinical trials: a meta‐analysis of longitudinal studies publication-title: Antivir Ther – volume: 18 start-page: 57 year: 2009 end-page: 60 article-title: Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? publication-title: J Gastrointest Liver Dis – volume: 24 start-page: 289 year: 1996 end-page: 293 article-title: An algorithm for grading activity in chronic hepatitis C publication-title: HEPATOLOGY – volume: 92 start-page: 1795 year: 1993 end-page: 1804 article-title: Activation‐dependent contractility of rat hepatic lipocytes in culture and in vivo publication-title: J Clin Invest – volume: 134 start-page: 1376 year: 2008 end-page: 1384 article-title: Virologic and histologic features of chronic hepatitis B virus‐infected asymptomatic patients with persistently normal ALT publication-title: Gastroenterology – volume: 134 start-page: 960 year: 2008 end-page: 974 article-title: Performance of transient elastography for the staging of liver fibrosis: a meta‐analysis publication-title: Gastroenterology – volume: 10 start-page: 40 year: 2010 article-title: Prevalence of liver fibrosis and risk factors in a general population using non‐invasive biomarkers (FibroTest) publication-title: BMC Gastroenterol – volume: 363 start-page: 157 year: 2004 end-page: 163 article-title: Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies publication-title: Lancet – volume: 293 start-page: G1147 year: 2007 end-page: G1154 article-title: Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 20 start-page: 1712 year: 2005 end-page: 1720 article-title: Community‐based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen‐negative infection and associated viral variants publication-title: J Gastroenterol Hepatol – volume: 3 start-page: e3857 year: 2008 article-title: Concordance in a world without a gold standard: a new non‐invasive methodology for improving accuracy of fibrosis markers publication-title: PLoS One – volume: 22 start-page: 775777 year: 2007 ident: R21-27-20241201 article-title: Guidelines for the assessment and management of nonalcoholic fatty liver disease in the AsiaPacific region: executive summary. publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.05002.x – volume: 92 start-page: 17951804 year: 1993 ident: R47-27-20241201 article-title: Activationdependent contractility of rat hepatic lipocytes in culture and in vivo. publication-title: J Clin Invest doi: 10.1172/JCI116769 – volume: 84 start-page: 1334 year: 2006 ident: R30-27-20241201 article-title: The double burden of malnutrition: case studies from six developing countries. publication-title: FAO Food Nutr Pap – volume: 35 start-page: 15301531 year: 2006 ident: R29-27-20241201 article-title: Shifting burden of diseaseepidemiological transition in India. publication-title: Int J Epidemiol doi: 10.1093/ije/dyl244 – volume: 363 start-page: 157163 year: 2004 ident: R13-27-20241201 article-title: Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. publication-title: Lancet – volume: 47 start-page: 592595 year: 2008 ident: R37-27-20241201 article-title: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. publication-title: Hepatology doi: 10.1002/hep.22056 – volume: 293 start-page: G1147G1154 year: 2007 ident: R9-27-20241201 article-title: Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00032.2007 – volume: 134 start-page: 960974 year: 2008 ident: R5-27-20241201 article-title: Performance of transient elastography for the staging of liver fibrosis: a metaanalysis. publication-title: Gastroenterology – volume: 371 start-page: 838851 year: 2008 ident: R20-27-20241201 article-title: Liver cirrhosis. publication-title: Lancet doi: 10.1016/S0140-6736(08)60383-9 – volume: 93 start-page: S9S30 year: 2008 ident: R14-27-20241201 article-title: Obesity and the metabolic syndrome in developing countries. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-1595 – volume: 60 start-page: 977984 year: 2011 ident: R6-27-20241201 article-title: Transient elastography as a screening tool for liver fibrosis and cirrhosis in a communitybased population aged over 45 years. publication-title: Gut doi: 10.1136/gut.2010.221382 – volume: 35 start-page: 190199 year: 1958 ident: R25-27-20241201 article-title: Onesecond needle biopsy of the liver. publication-title: Gastroenterology doi: 10.1016/S0016-5085(19)35563-5 – volume: 45 start-page: 12901297 year: 2007 ident: R34-27-20241201 article-title: Liver stiffness measurement predicts severe portal hypertension in patients with HCVrelated cirrhosis. publication-title: Hepatology doi: 10.1002/hep.21665 – volume: 18 start-page: 5760 year: 2009 ident: R31-27-20241201 article-title: Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? publication-title: J Gastrointest Liver Dis – volume: 50 start-page: 12671268 year: 2009 ident: R45-27-20241201 article-title: Liver biopsy: the best standard when everything else fails. publication-title: J Hepatol doi: 10.1016/j.jhep.2009.02.010 – volume: 38 start-page: 14491457 year: 2003 ident: R44-27-20241201 article-title: Sampling variability of liver fibrosis in chronic hepatitis C. publication-title: Hepatology – volume: 51 start-page: 828835 year: 2010 ident: R7-27-20241201 article-title: Pitfalls of liver stiffness measurement: a 5year prospective study of 13,369 examinations. publication-title: Hepatology doi: 10.1002/hep.23425 – volume: 48 start-page: 17181723 year: 2008 ident: R36-27-20241201 article-title: Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. publication-title: Hepatology doi: 10.1002/hep.22577 – volume: 54 start-page: 6471 year: 2011 ident: R39-27-20241201 article-title: Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis. publication-title: J Hepatol doi: 10.1016/j.jhep.2010.06.022 – volume: 51 start-page: 15931602 year: 2010 ident: R12-27-20241201 article-title: Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. publication-title: Hepatology doi: 10.1002/hep.23567 – volume: 31 start-page: 929938 year: 1999 ident: R24-27-20241201 article-title: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80297-9 – volume: 123 start-page: 13671384 year: 2002 ident: R27-27-20241201 article-title: AGA technical review on the evaluation of liver chemistry tests. publication-title: Gastroenterology doi: 10.1053/gast.2002.36061 – volume: 140 start-page: 19701979 year: 2011 ident: R2-27-20241201 article-title: Noninvasive tests for fibrosis and liver stiffness predict 5year outcomes of patients with chronic hepatitis C. publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.02.058 – volume: 44 start-page: 513514 year: 2006 ident: R11-27-20241201 article-title: Gender and liver: is the liver stiffness weaker in weaker sex? publication-title: Hepatology doi: 10.1002/hep.21306 – volume: 52 start-page: 206210 year: 2010 ident: R35-27-20241201 article-title: Liver stiffness is directly influenced by central venous pressure. publication-title: J Hepatol doi: 10.1016/j.jhep.2009.11.018 – volume: 49 start-page: 13351374 year: 2009 ident: R22-27-20241201 article-title: AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. publication-title: Hepatology doi: 10.1002/hep.22759 – volume: 24 start-page: 289293 year: 1996 ident: R4-27-20241201 article-title: An algorithm for grading activity in chronic hepatitis C. publication-title: Hepatology doi: 10.1002/hep.510240201 – volume: 10 start-page: 40 year: 2010 ident: R41-27-20241201 article-title: Prevalence of liver fibrosis and risk factors in a general population using noninvasive biomarkers (FibroTest). publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-10-40 – volume: 44 start-page: 521526 year: 2006 ident: R28-27-20241201 article-title: Global challenges in liver disease. publication-title: Hepatology doi: 10.1002/hep.21347 – volume: 54 start-page: 650659 year: 2011 ident: R43-27-20241201 article-title: Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a metaanalysis of diagnostic accuracy. publication-title: J Hepatol doi: 10.1016/j.jhep.2010.07.033 – volume: 48 start-page: 835847 year: 2008 ident: R1-27-20241201 article-title: Noninvasive evaluation of liver fibrosis by transient elastography. publication-title: J Hepatol doi: 10.1016/j.jhep.2008.02.008 – volume: 15 start-page: 617631 year: 2010 ident: R42-27-20241201 article-title: Biomarkers of liver injury for hepatitis clinical trials: a metaanalysis of longitudinal studies. publication-title: Antivir Ther doi: 10.3851/IMP1570 – volume: 41 start-page: 13131321 year: 2005 ident: R26-27-20241201 article-title: for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. publication-title: Hepatology doi: 10.1002/hep.20701 – volume: 28 start-page: 412419 year: 1985 ident: R19-27-20241201 article-title: Homeostasis model assessment: insulin resistance and Bcell function from fasting glucose and insulin concentrations in man. publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 132 start-page: 104105 year: 2010 ident: R33-27-20241201 article-title: The effect of Glissons capsule on the superficial elasticity measurements of the liver. publication-title: J Biomech Eng doi: 10.1115/1.4002369 – volume: 6 start-page: 828831 year: 2008 ident: R40-27-20241201 article-title: Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2008.03.005 – volume: 134 start-page: 13761384 year: 2008 ident: R3-27-20241201 article-title: Virologic and histologic features of chronic hepatitis B virusinfected asymptomatic patients with persistently normal ALT. publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.02.075 – volume: 56 start-page: 13301331 year: 2007 ident: R38-27-20241201 article-title: Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD). publication-title: Gut doi: 10.1136/gut.2007.126417 – volume: 24 start-page: 193203 year: 1992 ident: R46-27-20241201 article-title: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. publication-title: J Submicrosc Cytol Pathol – volume: 37 start-page: 802809 year: 2003 ident: R15-27-20241201 article-title: Hepatitis C virus infection in the general population: a communitybased study in West Bengal, India. publication-title: Hepatology doi: 10.1053/jhep.2003.50157 – volume: 366 start-page: 10591062 year: 2005 ident: R18-27-20241201 article-title: The metabolic syndromea new worldwide definition. publication-title: Lancet doi: 10.1016/S0140-6736(05)67402-8 – volume: 32 start-page: 255266 year: 2010 ident: R32-27-20241201 article-title: Dispersion and shear modulus measurements of porcine liver. publication-title: Ultrason Imaging doi: 10.1177/016173461003200405 – volume: 3 start-page: e3857 year: 2008 ident: R8-27-20241201 article-title: Concordance in a world without a gold standard: a new noninvasive methodology for improving accuracy of fibrosis markers. publication-title: PLoS One doi: 10.1371/journal.pone.0003857 – volume: 139 start-page: 4350 year: 1983 ident: R17-27-20241201 article-title: Ultrasonographical diagnosis of fatty liver: significance of the liverkidney contrast. publication-title: Tohoku J Exp Med doi: 10.1620/tjem.139.43 – volume: 20 start-page: 17121720 year: 2005 ident: R16-27-20241201 article-title: Communitybased epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigennegative infection and associated viral variants. publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2005.04070.x – volume: 48 start-page: 606613 year: 2008 ident: R10-27-20241201 article-title: Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. publication-title: J Hepatol doi: 10.1016/j.jhep.2007.11.020 – volume: 45 start-page: 507539 year: 2007 ident: R23-27-20241201 article-title: Chronic hepatitis B. publication-title: Hepatology – reference: 22419516 - Hepatology. 2012 Sep;56(3):1183-4; author reply 1184-5 |
SSID | ssj0009428 |
Score | 2.3307889 |
Snippet | The liver stiffness measure (LSM) needs to be explored in ethnically and anthropometrically diverse healthy subjects (to derive an acceptable normal range) and... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 584 |
SubjectTerms | Adult Biological and medical sciences Case-Control Studies Developing Countries Elasticity Elasticity Imaging Techniques Female Gastroenterology. Liver. Pancreas. Abdomen Hepatology Humans India Liver - physiopathology Liver Cirrhosis - diagnosis Liver Diseases - diagnosis Liver Diseases - physiopathology Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Metabolic diseases Middle Aged Obesity Obesity - physiopathology Reference Values ROC Curve |
Title | "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country |
URI | https://api.istex.fr/ark:/67375/WNG-8G2LP81Q-L/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.24694 https://www.ncbi.nlm.nih.gov/pubmed/21952989 https://www.proquest.com/docview/1766825559 https://www.proquest.com/docview/1776668555 https://www.proquest.com/docview/918933492 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRUJceEPdlmpACJWD02S9drxwqlDbCKVReVT0gGTtrtdq1eBEcSIBp_wELtzgz-WXMLN-REGthLhZ9ljWjmdnv9mZ_Yax552s2-E2C3yrpfQpE-jHYdr1cTnX2srIZNqxfQ6i3ql4exaerbHX9VmYkh-i2XCjmeH8NU1wpYu9JWnouR23OAZ3xAVKtVoEiN4vqaOkcH1VMepqU3ZZ1qxCbb7XvLmyFt0gtX6l2khVoHqysq_FVcBzFce6hejwDvtcD6GsP7lszaa6Zb7_xe74n2O8y25XABX2S4u6x9Zsfp_dPK5S8A_Yz8X814CA7nAx_w1DKusAdBNZRj4TvpRbjrDb_3D8EohJ3Bag8Ma5qyeBixw02gYMrcpB5SmMtC0sXDTHwopXsA_jpqvYYv6D1tkUHA0u0GEYULA86QWu18Xk20N2enjw8U3Pr3o7-AYxo_AFRlKxVSK2PNWRtQKBiwnRONK2iWJhwlRkFqEH14ghuOFtHWBkRFw_RMMeqeARW89Hud1gYMMwUzrNMhkaEbSlklIFWgQm5WkqjPLYbv2XE1MRn1P_jWFSUjbzBNWcODV77FkjOi7ZPq4SeuFMpZFQk0sqj-uGyafBURIf8f5J3HmX9D22s2JLzQsYxsUSvZ_HtmvjSirXUSTE2IlhO0Z6HnvaPMZJT5kcldvRjGRQKIpRyGNwjYzsIBQl7kmPPS7tdvn9jgyJeR8146zv-rEmvYMTd7H576Jb7BaiSl6Wtm-z9elkZp8gcpvqHTdF_wAIwEI3 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VVgIuvB-GUhaEUDk4dey140VcKmgbIIkKbUUvaLW7XqtVgxPlIQGn_AQu3ODP5Zcws04cBbUS4mbZY1k7np39Zmf2G4Bn9bxRD20e-VYL4VMm0E_jrOHjcq61FYnJtWP77CTNI_7uOD5egVfzszAlP0S14UYzw_lrmuC0Ib21YA09sf1aiNEdvwRr1NGbmPPffFyQRwnuOqti3BVQflnMeYWCcKt6dWk1WiPFfqXqSDVEBeVlZ4vzoOcyknVL0e51-DwfRFmBclYbj3TNfP-L3_F_R3kDrs0wKtsujeomrNjiFlxuz7Lwt-HndPKrQ1i3O538Zl2q7GDoKfKc3Cb7Uu46ss3WQfsFIzJxO2QKb5y4khJ2WjCN5sG6VhVMFRnraTu07LQ6GTZ8ybZZv2osNp38oKU2Y44Jl9F5GKbY4rAXc-0uBt_uwNHuzuHrpj9r7-AbhI3c5xhMpVbx1IaZTqzliF1MjPaRBSZJuYkznltEH6FGGBGaMNARBkdE90NM7ImK7sJq0SvsfWA2jnOlszwXseFRIJQQKtI8MlmYZdwoDzbnv1maGfc5teDoypK1OZSoZunU7MHTSrRfEn6cJ_Tc2UoloQZnVCHXiOWnzp5M98LWflr_IFsebCwZU_UCRnKpQAfowfrcuuTMewwlkXZi5I7BngdPqsc47ymZowrbG5MMCiUpCnnALpARdUSjRD_pwb3ScBffr4uYyPdRM878Lh6rbO7su4sH_y76GK40D9st2Xrbef8QriLIDMtK93VYHQ3G9hECuZHecPP1D_jURlM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJk288P0RGONACI2HdKnjpDE8TWxdga4asIk9IFl2bGvTSlr1QwKe-ifwwhv8c_1LODttqqJNQrxFyUWRL-fz73zn3xHyrG4bdWpsHBrFeegygWGW6EaIy7lShqe5VZ7ts5O2jtnbk-Rkhbyan4Up-SGqDTc3M7y_dhO8r-32gjT01PRrFIM7doWssTTirm_D7ocFdxRnvrEqhl2RSy_zOa1QRLerV5cWozWn16-uOFIOUT-2bGxxEfJcBrJ-JWpeJ5_nYygLUM5r45Gq5d__onf8z0HeINdmCBV2SpO6SVZMcYusH8xy8LfJz-nkV8ch3e508hu6rq4D0E9Y65wmfCn3HGGr_fHgBTgqcTMEiTdOfUEJnBWg0Diga2QBstDQU2Zo4Kw6FzZ8CTvQr9qKTSc_3EKrwfPggjsNAxIWR73AN7sYfLtDjpt7R69b4ay5Q5gjaGQhw1AqM5JlhmqVGsMQueQJWoeO8jRjeaKZNYg9qEIQQXMaqRhDI0f243jYUxnfJatFrzD3CZgksVJpa3mSszjiknMZKxbnmmrNchmQrflfFvmM-dw14OiKkrOZClSz8GoOyNNKtF_SfVwk9NybSiUhB-euPq6RiE-dfZHt0_ZhVn8v2gHZXLKl6gWM4zKO7i8gG3PjEjPfMRSOshPjdgz1AvKkeoyz3qVyZGF6YyeDQmmGQgGBS2R4HbGoI58MyL3Sbhffr_PEUe-jZrz1XT5W0do79BcP_l30MVk_3G2K9pvOu4fkKiJMWpa5b5DV0WBsHiGKG6lNP1v_APurRQI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%22Normal%22+liver+stiffness+measure+%28LSM%29+values+are+higher+in+both+lean+and+obese+individuals%3A+a+population-based+study+from+a+developing+country&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Das%2C+Kausik&rft.au=Sarkar%2C+Rajib&rft.au=Ahmed%2C+Sk+Mahiuddin&rft.au=Mridha%2C+Asit+R&rft.date=2012-02-01&rft.issn=1527-3350&rft.eissn=1527-3350&rft.volume=55&rft.issue=2&rft.spage=584&rft_id=info:doi/10.1002%2Fhep.24694&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |